Case Study: a client achieves clinical trial readiness with Kymanox's inhaler gap assessment and CMO selection support

A Kymanox Case Study

Comprehensive Gap Assessment for Novel Inhaler - Case Study

The client, a pharmaceutical company developing a novel inhaler, faced challenges ensuring compliance with combination product regulations and lacked the in-house expertise to select the optimal inhaler technology and contract manufacturing organization for its Phase II clinical trials. They engaged Kymanox for its quality and compliance services to perform a comprehensive gap assessment.

Kymanox developed targeted gap assessments with actionable recommendations and conducted a comprehensive landscape evaluation of available inhaler technologies. This solution enabled the client to effectively remediate critical compliance gaps and successfully select both an inhaler technology and a CMO. Kymanox's support streamlined the client's preparation for clinical trial execution.


View this case study…

Kymanox

58 Case Studies